Medical Devices in Canada – Transitioning into a stronger proactive regulatory approach

Overview

In today's ever-evolving healthcare landscape, regulatory and quality professionals in the medical device industry face continuous challenges to ensure their products meet the stringent requirements for market access. Join us for an informative webinar where we will explore the proactive approach to navigate the changing medical device regulatory landscape in Canada and beyond.

Featured Topics

• Introduction to Medtech Canada
• Impending Changes in Canadian Medical Device Regulations
• Beyond the Food and Drug Act: Other Regulatory Changes*
• Q&A and Discussion

Learning Objectives

• Gain a deep understanding of Medtech Canada's role and mission in shaping the medical device regulatory landscape.
• Stay informed about impending changes in Canadian medical device regulations and their global alignment.
• Explore regulatory changes outside of the Food and Drug Act, affecting medical devices in various sectors.
• Develop proactive strategies to address regulatory challenges and ensure market access.
• Learn from real-life case studies and engage in interactive discussions.
• Connect with industry experts and fellow professionals to expand your network.

Who should attend

• Regulatory Affairs Professionals
• Quality Assurance Specialists
• Compliance Officers, Medical Device Specialists

Meet the Speaker

This webinar will be led by Mia Spiegelman, Vice President Regulatory Affairs at Medtech Canada. Mia holds a B.Sc. in Chemistry from York University as well as Certification in Pharmaceutical Regulatory Affairs and Quality Operations from Seneca College. Throughout her 23 years in industry, she has worked in various Medical Device, Pharmaceutical, Cosmetic and Consulting companies while holding various roles within the Quality and Regulatory fields. Her current role responsibilities include developing, leading, implementing and managing the Regulatory Affairs strategic initiatives for Medtech Canada and its members in order to ensure that Canada has a globally competitive regulatory environment.